BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peter AE, Sandeep BV, Rao BG, Kalpana VL. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19. Front Pharmacol 2020;11:583777. [PMID: 33708109 DOI: 10.3389/fphar.2020.583777] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Papadopoulos KI, Sutheesophon W, Manipalviratn S, Aw TC. Age and genotype dependent erythropoietin protection in COVID-19. World J Stem Cells 2021;13:1513-29. [PMID: 34786155 DOI: 10.4252/wjsc.v13.i10.1513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sengupta S, Bhattacharyya D, Kasle G, Karmakar S, Sahu O, Ganguly A, Addya S, Das Sarma J. Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses. Front Cell Infect Microbiol 2021;11:729622. [PMID: 34513735 DOI: 10.3389/fcimb.2021.729622] [Reference Citation Analysis]
4 Davidson M, Menon S, Chaimani A, Evrenoglou T, Ghosn L, Graña C, Henschke N, Cogo E, Villanueva G, Ferrand G, Riveros C, Bonnet H, Kapp P, Moran C, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P, Boutron I. Interleukin-1 blocking agents for treating COVID-19. Cochrane Database Syst Rev 2022;1:CD015308. [PMID: 35080773 DOI: 10.1002/14651858.CD015308] [Reference Citation Analysis]
5 Alberca RW, Benard G, Alberca GGF, Sato MN. SARS-CoV-2 infection in liver transplant recipients: A complex relationship. World J Gastroenterol 2021; 27(44): 7734-7738 [PMID: 34908810 DOI: 10.3748/wjg.v27.i44.7734] [Reference Citation Analysis]
6 Skesters A, Kustovs D, Lece A, Moreino E, Petrosina E, Rainsford KD. Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery. Inflammopharmacol. [DOI: 10.1007/s10787-022-00925-z] [Reference Citation Analysis]
7 Monschein T, Zrzavy T, Löbermann M, Winkelmann A, Berger T, Rommer P, Hartung HP, Zettl UK. [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations]. Nervenarzt 2021. [PMID: 34232359 DOI: 10.1007/s00115-021-01155-4] [Reference Citation Analysis]
8 Wang S, Xu S, Zhou J, Zhang L, Mao X, Yao X, Liu C. Luteolin transforms the polarity of bone marrow-derived macrophages to regulate the cytokine storm. J Inflamm (Lond) 2021;18:21. [PMID: 34059076 DOI: 10.1186/s12950-021-00285-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Stoia M, Oancea S. Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends. Antioxidants 2022;11:638. [DOI: 10.3390/antiox11040638] [Reference Citation Analysis]
11 Oh K, Adnan M, Cho D. Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19. CIMB 2022;44:1597-609. [DOI: 10.3390/cimb44040109] [Reference Citation Analysis]
12 Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy 2021. [PMID: 34820848 DOI: 10.1111/all.15188] [Reference Citation Analysis]
13 Shekhawat J, Gauba K, Gupta S, Purohit P, Mitra P, Garg M, Misra S, Sharma P, Banerjee M. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm. Indian J Clin Biochem 2021;:1-11. [PMID: 34177139 DOI: 10.1007/s12291-021-00989-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Paparo L, Bruno C, Ferrucci V, Punto E, Viscardi M, Fusco G, Cerino P, Romano A, Zollo M, Berni Canani R. Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes. J Funct Foods 2021;87:104787. [PMID: 34630633 DOI: 10.1016/j.jff.2021.104787] [Reference Citation Analysis]
15 Varodi C, Coros M, Pogăcean F, Ciorîţă A, Turza A, Pruneanu S. Nitrogen-Doped Graphene-Based Sensor for Electrochemical Detection of Piroxicam, a NSAID Drug for COVID-19 Patients. Chemosensors 2022;10:47. [DOI: 10.3390/chemosensors10020047] [Reference Citation Analysis]
16 Sasi M, Kumar S, Kumar M, Thapa S, Prajapati U, Tak Y, Changan S, Saurabh V, Kumari S, Kumar A, Hasan M, Chandran D, Radha, Bangar SP, Dhumal S, Senapathy M, Thiyagarajan A, Alhariri A, Dey A, Singh S, Prakash S, Pandiselvam R, Mekhemar M. Garlic (Allium sativum L.) Bioactives and Its Role in Alleviating Oral Pathologies. Antioxidants (Basel) 2021;10:1847. [PMID: 34829718 DOI: 10.3390/antiox10111847] [Reference Citation Analysis]
17 Qin J, Guo C, Yang L, Liang X, Jiao A, Lai KP, Yang B. Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19. Bioengineered 2021;12:12461-9. [PMID: 34931923 DOI: 10.1080/21655979.2021.2005876] [Reference Citation Analysis]
18 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Reference Citation Analysis]
19 Absalón-Aguilar A, Rull-Gabayet M, Pérez-Fragoso A, Mejía-Domínguez NR, Núñez-Álvarez C, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J, Ponce-de-León A, González-Lara F, Martín-Nares E, Montesinos-Ramírez S, Ramírez-Alemón M, Ramírez-Rangel P, Márquez MF, Plata-Corona JC, Juárez-Vega G, Gómez-Martín D, Torres-Ruiz J. Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID). J Gen Intern Med 2021. [PMID: 34755269 DOI: 10.1007/s11606-021-07203-8] [Reference Citation Analysis]
20 Blanco-Salas J, Hortigón-Vinagre MP, Morales-Jadán D, Ruiz-Téllez T. Searching for Scientific Explanations for the Uses of Spanish Folk Medicine: A Review on the Case of Mullein (Verbascum, Scrophulariaceae). Biology (Basel) 2021;10:618. [PMID: 34356473 DOI: 10.3390/biology10070618] [Reference Citation Analysis]
21 Wang JB, Andrade-Cetto A, Echeverria J, Wardle J, Yen HR, Heinrich M. Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic. Front Pharmacol 2021;12:798674. [PMID: 34925048 DOI: 10.3389/fphar.2021.798674] [Reference Citation Analysis]
22 Bohländer F, Riehl D, Weißmüller S, Gutscher M, Schüttrumpf J, Faust S. Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI. Front Immunol 2021;12:700429. [PMID: 34177967 DOI: 10.3389/fimmu.2021.700429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]